# POSACONAZOLE
> **ANDA209983** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-12-26
## Drug
- **FDA Application Number:** ANDA209983
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POSACONAZOLE
- **Generic name:** POSACONAZOLE
- **Active ingredients:** POSACONAZOLE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresensius Kabi USA, LLC
- **First approval:** 2023-12-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209983)
---
*AI Analytics · CC0 1.0*